You are viewing: Japan ECMO Machines Market analysis
Part of: ECMO Machines Market (Global)

The Japan ECMO Machines Market was valued at $14.85 Million in 2025 and projected to reach to $19.35 Million by 2030, representing a compound annual growth rate of 5.4%. Japan's ECMO machines market is poised for steady growth driven by its aging population and sophisticated healthcare ecosystem.

Japan ECMO Machines Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Japan ECMO Machines Market Trends and Insights

  • Japan's advanced healthcare infrastructure and aging population are driving demand for extracorporeal membrane oxygenation technology, particularly in critical care and cardiac surgery settings.
  • The market reflects Japan's commitment to adopting cutting-edge medical devices to support patient outcomes in life-threatening conditions. The growth trajectory in Japan is supported by increasing prevalence of cardiovascular and respiratory diseases, coupled with rising healthcare expenditure and technological innovation in ECMO systems.
  • Japan's regulatory environment and strong hospital networks facilitate the adoption of ECMO machines across major medical centers.
  • Between 2025 and 2030, Japan is expected to see expanded clinical applications and improved reimbursement pathways, further accelerating market penetration in the country..

Key Market Statistics

  • CAGR (2025-2030) 5.4% CAGR
  • Market Size, 2025 ~USD 14.85 Million
  • Forecast, 2030 ~USD 19.35 Million
  • Country Japan

Japan ECMO Machines Market Overview

Aging Population Driving Demand :

Japan's rapidly aging demographic, with over 29% of the population aged 65+, is significantly increasing the prevalence of cardiac and respiratory conditions requiring ECMO support in critical care settings.

Advanced Healthcare Infrastructure :

Japan's world-class medical facilities and high healthcare spending per capita create an ideal environment for adoption of sophisticated ECMO technologies in major hospitals and cardiac centers.

Strong Market Growth Trajectory :

The Japan ECMO machines market is projected to grow from USD 14.85 million in 2025 to USD 19.35 million by 2030, with a steady CAGR of 5.4%, outpacing many developed markets.

Regulatory Support and Innovation :

Japan's PMDA approval processes and investment in medical device innovation are facilitating faster market entry for advanced ECMO systems and supporting clinical adoption in tertiary care hospitals.

Japan ECMO Machines Market Dynamics

  • The country's emphasis on advanced cardiac and critical care solutions, combined with high healthcare expenditure, creates sustained demand for extracorporeal membrane oxygenation technologies.
  • Major Japanese hospitals are increasingly integrating ECMO systems into their cardiac surgery and intensive care protocols. Looking ahead to 2030, the market will benefit from technological advancements, expanded clinical applications, and growing awareness among healthcare providers.
  • However, high equipment costs and the need for specialized training may moderate growth rates.
  • Strategic partnerships between international ECMO manufacturers and Japanese healthcare institutions will be critical for market expansion and localization of services..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Japan's ECMO machines market is valued at USD 14.85 million in 2025 and will reach USD 19.35 million by 2030, growing at 5.4% CAGR.
    • Japan's aging population and high prevalence of cardiovascular diseases are primary drivers of ECMO machine adoption in the country.
    • Japan's advanced healthcare infrastructure and strong regulatory framework support rapid integration of ECMO technology across major hospitals.
    • Improved reimbursement policies and expanded clinical applications are expected to accelerate market growth in Japan through 2030.

    ECMO Machines Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR) (Application)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.8% from 2025 to 2030
    Largest Segment ADULT PATIENTS (Patient Type)
    Market Size Base Year (Billions) ~USD 0.65 (2025)
    Revenue Forecast (Billions) ~USD 0.86 (2030)
    Segments Covered Product, Type, Modality, Patient Type, Application, End User

    Japan ECMO Machines Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Components
    • Machines

    By Type

    • Accessories
    • Cannulas
    • Controllers
    • Oxygenators
    • Pumps

    By Modality

    • Arteriovenous Ecmo
    • Venoarterial Ecmo
    • Venovenous Ecmo

    By Patient Type

    • Adult Patients
    • Neonates
    • Pediatric Patients

    By Application

    • Cardiac Applications
    • Extracorporeal Cardiopulmonary Resuscitation (Ecpr)
    • Respiratory Applications

    By End User

    • Academic & Research Institutions
    • Hospitals
    • Specialty Clinics

    JAPAN: ECMO MACHINES MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    ACADEMIC & RESEARCH INSTITUTIONS4.384.524.674.835.015.215.435.663.9
    HOSPITALS17.7518.4919.2920.1621.1122.1623.2924.534.9
    SPECIALTY CLINICS2.983.043.123.23.293.393.493.613
    TOTAL25.126.0427.0828.1829.4130.7532.2133.84.5

    Target Audience

    • Medical Device Manufacturers : ECMO equipment producers need Japan-specific market data to develop localized product strategies, identify distribution partnerships, and forecast revenue potential in this high-value healthcare market.
    • Hospital and Healthcare Administrators : Japanese hospital leaders require market insights to justify ECMO system investments, benchmark adoption rates against peer institutions, and plan critical care infrastructure upgrades.
    • Investment and Private Equity Firms : Investors targeting Japan's healthcare sector need detailed market analysis to evaluate acquisition targets, assess growth potential, and make informed capital allocation decisions in ECMO technology.
    • Healthcare Consultants and Analysts : Consulting firms advising Japanese healthcare organizations require comprehensive market data to support strategic recommendations, competitive positioning, and technology adoption roadmaps.
    • Regulatory and Compliance Professionals : Regulatory specialists need Japan-specific market context to navigate PMDA approval processes, understand market dynamics, and ensure compliant market entry strategies for ECMO devices.

    Key Companies in the Japan ECMO Machines Market

    CompanyHQOwnershipStrongest segments
    GETINGESwedenPublic CompanyAcute Care Therapies,Surgical Workflows,Life Science,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,
    FRESENIUS MEDICAL CARE AGGermanyPublic CompanyDialysis services (outpatient and in-hospital ESRD/acute),Dialysis machines, cyclers, and water treatment systems,Dialysis consumables and solutions,
    LIVANOVA PLCUnited KingdomPublic CompanyCardiopulmonary (heart-lung machines, oxygenators, autotransfusion, perfusion tubing, cannula, services),Neuromodulation (VNS Therapy for epilepsy and depression, aura6000 development),
    NIPROJapanPublic CompanyDialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products, functional products,Pharmaceutical-Related (CDMO for injectables and oral drugs, kit products),
    WEIGAO GROUP CO., LTD.ChinaPublic CompanyMedical Device Products (infusion, clinical nursing, perioperative, urinary, rehab, extracorporeal circulation),Orthopedic Products (spine, joint, trauma, sports medicine, bone repair, spinal endoscope),Pharma Packaging Products (prefilled systems, packaging consumables, automatic drug delivery),
    ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
    MICROPORT SCIENTIFIC CORPORATIONChinaPublic CompanyCardiovascular Devices,Orthopedics Devices,Cardiac Rhythm Management,

    GETINGE

    Getinge is a Swedish public company founded in 1904 that employs 11,754 people and operates in the medical technology sector.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees specializing in medical devices and healthcare solutions.

    TERUMO CORPORATION

    Terumo Corporation is a Japanese public company established in 1921 with 30,591 employees, operating in the medical device and healthcare industry.

    FRESENIUS MEDICAL CARE AG

    Fresenius Medical Care AG is a German public company founded in 1996 with 108,165 employees, providing dialysis and renal care services globally.

    LIVANOVA PLC

    LivaNova PLC is a United Kingdom-based public company founded in 2015 with 3,300 employees, focused on neuromodulation and cardiac surgery solutions.

    NIPRO

    Nipro is a Japanese public company established in 1947 with 38,593 employees, manufacturing medical devices and pharmaceutical products.

    WEIGAO GROUP CO., LTD.

    Weigao Group Co., Ltd. is a Chinese public company founded in 1988 with 13,307 employees, specializing in medical device manufacturing.

    ABBOTT

    Abbott is a United States-based public company founded in 1888 with 115,000 employees, operating across diagnostics, medical devices, nutrition, and pharmaceuticals.

    MICROPORT SCIENTIFIC CORPORATION

    MicroPort Scientific Corporation is a Chinese public company established in 1998 with 6,547 employees, developing and manufacturing medical devices.

    Reasons to Buy this Report

    • Japan-Specific Market Sizing : Obtain precise market valuation data for Japan's ECMO segment with verified 2025 baseline (USD 14.85M) and 2030 forecast (USD 19.35M), enabling accurate financial planning and investment decisions.
    • Demographic Insights for Japan : Understand how Japan's unique aging population structure and healthcare needs are creating distinct demand patterns for ECMO technology compared to global markets.
    • Competitive Landscape in Japan : Identify key players, market share distribution, and competitive strategies specific to Japan's ECMO market to inform market entry or expansion strategies.
    • Regulatory and Reimbursement Framework : Access Japan-specific regulatory pathways, PMDA requirements, and healthcare reimbursement structures that directly impact ECMO device commercialization and adoption rates.
    • Growth Opportunity Assessment : Leverage Japan's 5.4% CAGR forecast to identify high-potential segments, geographic hotspots, and clinical applications driving market expansion through 2030.

    Frequently asked questions

    What is the current size of Japan's ECMO machines market?

    Japan's ECMO machines market is estimated at USD 14.85 million in 2025.

    What is the projected market size for ECMO machines in Japan by 2030?

    Japan's ECMO machines market is projected to reach USD 19.35 million by 2030.

    What is the CAGR for Japan's ECMO machines market?

    Japan's ECMO machines market is expected to grow at a compound annual growth rate (CAGR) of 5.4% from 2025 to 2030.

    What factors are driving growth in Japan's ECMO machines market?

    Key growth drivers in Japan include an aging population, rising prevalence of cardiovascular and respiratory diseases, increased healthcare expenditure, and technological advancements in ECMO systems.

    How does Japan's healthcare infrastructure support ECMO machine adoption?

    Japan's advanced healthcare infrastructure, strong hospital networks, favorable regulatory environment, and improving reimbursement pathways facilitate widespread adoption of ECMO machines across major medical centers.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size of the ECMO machines market. Exhaustive secondary research was done to collect information on the ECMO market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the ECMO market.

    Secondary Research

    This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the ECMO market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the ECMO market. Primary sources from the demand side included hospitals, academic & research institutions, specialty clinics, researchers, lab technicians, purchase managers, and stakeholders in corporate & government bodies.

    The following is a breakdown of the primary respondents:

    ECMO Machines Market

    Note 1: C-level primaries include CEOs, COOs, and CTOs.

    Note 2: Others include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ECMO market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    ECMO Machines Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ECMO machines and components. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    An ECMO machine acts as an artificial heart and lung for a patient whose heart or lungs cannot provide enough blood flow or oxygen into the blood. ECMO is used after other methods of supporting the heart and lungs do not work. The goal of ECMO is to let the heart and lungs recover while the patient is supported by the ECMO machine.

    Stakeholders

    • Manufacturers of ECMO Machine Products and Related Devices
    • Suppliers and Distributors of ECMO Machine Devices
    • Hospitals, Clinics, and Medical Colleges
    • Medical Device Procurement Agencies
    • Government Bodies/Municipal Corporations
    • Business Research and Consulting Service Providers
    • Venture Capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the oxygen concentrators market based on product, modality, patient type, application, end user, and region  
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall oxygen concentrators market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the oxygen concentrators market in six regions, namely, North America (US and Canada), Europe (Germany, UK, France, Spain, Italy, and Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), Middle East & Africa, and GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full ECMO Machines Market Report

    Full forecast, segment splits, and company analysis for all ECMO Machines Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status